
Sign up to save your podcasts
Or


A new artificial intelligence (AI) model, called TxGNN, has been developed to identify potential drug candidates for rare diseases, many of which currently have no treatments.
By Artificial InsightsA new artificial intelligence (AI) model, called TxGNN, has been developed to identify potential drug candidates for rare diseases, many of which currently have no treatments.